Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study
Authors:
- Thomas C WilliamsTWThomas C Williams
- Elizabeth WastnedgeEWElizabeth Wastnedge
- Gina McAllisterGMGina McAllister
- Ramya BhatiaRBRamya Bhatia
- Kate CuschieriKCKate Cuschieri
- Kallirroi KefalaKKKallirroi Kefala
- Fiona J HamiltonFHFiona J Hamilton
- Ingólfur JohannessenIJIngólfur Johannessen
- Ian F. LaurensonILIan F. Laurenson
- Jill ShepherdJSJill Shepherd
- Alistair StewartASAlistair Stewart
- Donald WatersDWDonald Waters
Preprint
Abstract
Objectives: To determine the sensitivity and specificity of RT-PCR testing of upper respiratory tract (URT) samples from hospitalised patients with COVID-19, compared to the gold standard of a clinical diagnosis. Methods: All URT RT-PCR testing for SARS-CoV-2 in NHS Lothian, Scotland, United Kingdom between the 7 th of February and 19 th April 2020 (inclusive) was reviewed, and hospitalised patients were identified. All URT RT-PCR tests were analysed for each patient to determine the sequence of negative and positive results. For those who were tested twice or more but never received a positive result, case records were reviewed, and a clinical diagnosis of COVID-19 allocated based on clinical features, discharge diagnosis, and radiology and haematology results. For those who had negative URT RT-PCR tests but a clinical diagnosis of COVID-19, respiratory samples were retested using a multiplex respiratory panel, a second SARS-CoV-2 RT-PCR assay, and a human RNase P control. Results: Compared to the gold standard of a clinical diagnosis of COVID-19, the sensitivity of an initial URT RT-PCR for COVID-19 was 82.2% (95% confidence interval 79.0-85.1%). Two consecutive URT RT-PCR tests increased sensitivity to 90.6% (CI 88.0-92.7%). A further 2.2% and 0.9% of patients who received a clinical diagnosis of COVID-19 were positive on a third and fourth test. Conclusions: The sensitivity of a single RT-PCR test of an URT sample in hospitalised patients is 82.2%. Sensitivity increases to 90.6% when patients are tested twice. A proportion of cases with clinically defined COVID-19 never test positive on URT RT-PCR despite repeated testing.Keywords
All Related Versions
- Published version: Wellcome Open Research, 5, 254.
This publication has 25 references indexed in Scilit:
- Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-AnalysisRadiology, 2020
- Sensitivity of Chest CT for COVID-19: Comparison to RT-PCRRadiology, 2020
- Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesThe Lancet Infectious Diseases, 2020
- Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?European Journal of Radiology, 2020
- Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical SpecimensJournal of Clinical Microbiology, 2020
- FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEWmedRxiv, 2020
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA, 2020
- Nosocomial Infections Among Patients with COVID-19, SARS and MERS: A Rapid Review and Meta-AnalysismedRxiv, 2020
- Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive StudyClinical Infectious Diseases, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020